Resveratrol treatment has been found to influence similar processes when administered with gold nanoparticles in breast cancer cells: treatment (10 μM) inhibited MMP-9 at the mRNA and protein levels and reduced its activity by downregulating the NF-κB, PI3 K/Akt, and MAPK/ERK pathways. The gene discussed is MMP9; the disease is breast carcinoma.